Miguel Ángel
González-Gay Mantecón
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Canarias (48)
2024
-
Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up
Seminars in Arthritis and Rheumatism, Vol. 66
-
Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 42, Núm. 8, pp. 1564-1570
-
Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients
Journal of Clinical Medicine, Vol. 13, Núm. 3
-
Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus
Life, Vol. 14, Núm. 4
-
Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis
Journal of Rheumatology
-
Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 42, Núm. 9, pp. 1773-1780
-
Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis
Frontiers in Immunology, Vol. 15
-
Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus
Biomedicines, Vol. 12, Núm. 5
-
Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients
RMD open, Vol. 10, Núm. 2
-
The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
The complement system is linked to insulin resistance in patients with systemic lupus erythematosus
Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121
-
Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period
RMD open, Vol. 10, Núm. 2
2023
-
Alpha-Klotho protein in systemic lupus erythematosus
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 41-47
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
-
Blood Composite Scores in Patients with Systemic Lupus Erythematosus
Biomedicines, Vol. 11, Núm. 10
-
Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy
Clinical and experimental rheumatology, Vol. 41, Núm. 7, pp. 1537-1543
-
Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis
Life, Vol. 13, Núm. 1
-
Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73
-
Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
Frontiers in Immunology, Vol. 14